Adaptive NK Cells Rapidly Expand during Acute HIV Infection and Persist Despite Early Initiation of Antiretroviral Therapy
- 1 April 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 212 (10) , 1553-1563
Abstract
HIV is associated with NK cell dysfunction and expansion of adaptive-like NK cells that persist despite antiretroviral therapy (ART). We investigated the timing of NK cell perturbations during acute HIV infection and the impact of early ART initiation. PBMCs and plasma were obtained from people with HIV (PWH; all men who have sex with men; median age, 26.0 y) diagnosed during Fiebig stages I, II, III, or IV/V. Participants initiated ART a median of 3 d after diagnosis, and immunophenotyping was performed at diagnosis and longitudinally after ART. Anti-CMV Abs were assessed by ELISA. Samples from matched HIV-uninfected males were also analyzed. Proportions of adaptive NK cells (A-NKs; defined as Fcε-Receptor-1γ–) were expanded at HIV diagnosis at all Fiebig stages (pooled median 66% versus 25% for controls; p < 0.001) and were not altered by early ART initiation. Abs to CMV immediate early protein were elevated in PWH diagnosed in Fiebig stages III and IV/V (p < 0.03 for both). Proportions of A-NKs defined as either Fcε-Receptor-1γ− or NKG2C+/CD57+ were significantly associated with HIV DNA levels at diagnosis (p = 0.046 and 0.029, respectively) and trended toward an association after 48 wk of ART. Proportions of activated HLA-DR+/CD38+ NK cells remained elevated in PWH despite early ART initiation. NK cell activation and A-NK expansion occur very early after HIV transmission, before T cell activation, and are not altered by ART initiation during acute infection. A-NKs may contribute to HIV control and thus be useful for HIV cure.Keywords
Funding Information
- National Health and Medical Research Council of Australia (1048536)
This publication has 71 references indexed in Scilit:
- Acute HIV-1 infection viremia associate with rebound upon treatment interruptionMed, 2022
- Immune correlates of HIV-1 reservoir cell decline in early-treated infantsCell Reports, 2022
- Identification of the predominant human NK cell effector subset mediating ADCC against HIV‐infected targets coated with BNAbs or plasma from PLWHEuropean Journal of Immunology, 2021
- HLA-DR-expressing NK cells: Effective killers suspected for antigen presentationJournal of Leukocyte Biology, 2020
- CD69: from activation marker to metabolic gatekeeperEuropean Journal of Immunology, 2017
- Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1+NK cellsEuropean Journal of Immunology, 2016
- Cytomegalovirus antibody and vascular pathology in renal transplant recipientsJournal of Medical Virology, 2016
- Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set PointImmunity, 2015
- Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected IndividualsImmunity, 2015
- Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector FunctionImmunity, 2015